As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

the contribution of emerging markets to the growth of the pharmaceutical market has increased from ... and China to become key nodal points." Analysis of MNCs and companies from emerging countries ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

While modern society’s relationship with mental health as evolved in recent decades, pharmaceutical innovation has yet to keep pace, mostly due ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arcus Biosciences (RCUS – Research Report), ...

Some critical factors influencing the adoption of generative AI in the pharmaceutical industry include: For these reasons, Enterprise Gen AI, especially in fields with high stakes like pharma ...

Discover key insights from Pharming Group's Q4 2024 earnings call. Explore strong revenue growth, RUCONEST & Joenja drivers, and 2025 strategic priorities.

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.

Bacil Pharma Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 21.55 Crore) operating in Pharmaceuticals sector. Bacil Pharma Ltd. key Products/Revenue Segments ...